Gilead Sciences (NasdaqGS:GILD) recently entered an exclusive agreement with Kymera Therapeutics to advance a molecular glue ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

The drug nearly eliminated HIV's spread among people who received an injection every six months. But some experts worry about how accessible it will be.

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...